Physician profile
Liana Gabriela Seldin
NPI 1063501518
$4,473.25
in general payments reported to CMS, 2019-2025
27 companies · $820 in 2025
The $820 reported for 2025 was more than what 84% of Primary Podiatric Medicine providers received nationally (typical 2025 total: $232).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $478 · 2020: $1,596 · 2021: $370 · 2022: $653 · 2023: $340 · 2024: $217 · 2025: $820.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,274 · Travel and Lodging: $103.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,273.95 |
| Travel and Lodging | $103.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $1,871.14 | 2019-2023 | |
| Paratek Pharmaceuticals, INC. | $363.24 | 2020-2025 | Nuzyra |
| Aroa Biosurgery Incorporated | $276.17 | 2022-2023 | |
| Bioventus LLC | $254.82 | 2019-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Nevro Corp. | $232.90 | 2021-2023 | Senza |
| Innovation Technologies INC | $198.87 | 2025 | Irrisept |
| Horizon Therapeutics Plc | $144.93 | 2021-2023 | Krystexxa |
| Grt US Holding, INC. | $136.07 | 2021-2022 | |
| Medline Industries Lp | $134.53 | 2019 | |
| Organogenesis INC. | $132.15 | 2019-2025 | Apligraf |
| Southern Edge Orthopaedics, INC. | $111.41 | 2025 | |
| Convatec INC. | $69.85 | 2024 | |
| Smith+Nephew, INC. | $69.59 | 2019-2021 | |
| Depuy Synthes Sales INC. | $52.66 | 2022 | |
| Averitas Pharma INC. | $47.33 | 2025 | Qutenza |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $46.33 | 2023-2024 | Dalvance, Teflaro |
| Zimmer Biomet Holdings, INC. | $43.84 | 2019-2020 | |
| Amgen INC. | $42.76 | 2024 | Krystexxa |
| Stryker Corporation | $40.66 | 2025 | Augment Injectable, Futura Csi |
| Alfasigma USA, INC. | $35.38 | 2021-2022 | |
| Globus Medical, INC. | $30.49 | 2025 | Senza |
| Medela LLC | $30.34 | 2020 | |
| Djo, LLC | $26.10 | 2025 | Cmf |
| Next Science LLC | $25.00 | 2024 | Blastx, Surgx, Xperience |
| Sandoz INC. | $22.15 | 2019 | |
| Melinta Therapeutics, LLC | $17.52 | 2021 | |
| Kerecis Limited | $17.02 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Liana Seldin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.